In This Section

Newsroom

  • News June 27, 2014

    Temple Lung Center Offers Promising New Drug for Idiopathic Pulmonary Fibrosis

    A new investigational drug that could be a game changer in the treatment of idiopathic pulmonary fibrosis (IPF) is being offered to patients at Temple Lung Center as part of a limited "expanded access" program in advance of the drug's regulatory approval.
     
    Results of a recently published phase III trial showed that the drug, pirfenidone, slowed disease progression in patients with IPF, a debilitating and deadly lung condition. The need for new therapies for IPF is critical, given that the median time of survival for patients is two years from the time of diagnosis.
     

  • News June 23, 2014

    Medical School Curriculum Getting a Makeover

    On June 5, faculty gathered for Temple University School of Medicine's (TUSM) annual spring education retreat. The working session, Preparing Future Physicians to Meet the Healthcare Needs of Society, was part of a strategic planning initiative launched in January to ensure that the School is ready to prepare tomorrow's graduates for emerging trends in medicine and healthcare delivery.
     

  • News June 20, 2014

    Temple Hosts Regional Symposium on Orthopaedic Trauma

    The 6th Annual Philadelphia Orthopaedic Trauma Symposium was held in the Medical Education and Research Building (MERB) on June 6th – 7th.

  • News June 18, 2014

    To Drive or Not Following ICD Implantations?

    Driving is a privilege shared by approximately 200 million Americans. Drivers not only enjoy the independence that comes with having a license, but also the ability to complete daily tasks such as going to work, the grocery store, the doctor and the pharmacy.

  • News June 13, 2014

    A Showcase Of Talent: The Department Of Medicine's 2014 Research Forum

    The Department of Medicine showcased the talent of its young physicians at the 2014 Sol Sherry Fellows and Residents Research Symposium – held on June 11, in Temple University School of Medicine's (TUSM) Medical Education and Research Building (MERB).
     

  • News June 05, 2014

    Temple University Hospital Investigating Whether Ibuprofen Can Reverse the Effects of Emphysema

    Temple University Hospital is participating in a multi-site, nationwide phase II clinical trial that is testing whether ibuprofen can reverse the effects of emphysema. Temple is one of only three medical centers in the country, and the only one in the Philadelphia region, chosen to take part in the three-year, $4.4 million study funded by the National Institutes of Health’s National Heart, Lung and Blood Institute.
     

  • News June 02, 2014

    Remembering Lewis Katz – From Larry Kaiser, MD, FACS

    Dear Colleagues,

    As I am sure you have heard, Temple University and Temple Health lost a great friend this weekend with the tragic death of Lewis Katz, who served as a long-time member of the University's Board of Trustees and a member of the Boards of Temple University Health System (TUHS) and Fox Chase Cancer Center (FCCC).

  • News May 30, 2014

    Cardiomyopathy Program and Associate Director of the Advanced Heart Failure and Transplantation Program at Temple

    Daniel L. Dries, MD, MPH, FACC, has been appointed Director of the Familial Cardiomyopathy Program and Associate Director of the Advanced Heart Failure and Transplantation Program at the Temple Heart and Vascular Institute, and Professor of Medicine at Temple University School of Medicine, effective June 1, 2014.

Pages